Andrew Nicholls

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*

Michael Hale, Andrew Nicholls, Roy Bullingham et al. · Clinical Pharmacology & Therapeutics · 1998 · 399 citations

Medicine, Pharmacokinetics, Pharmacology +16

Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous Administration

Roy Bullingham, Scot Monroe, Andrew Nicholls et al. · The Journal of Clinical Pharmacology · 1996 · 318 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Mycophenolic Acid Area under the Curve Values in African American and Caucasian Renal Transplant Patients Are Comparable

Leslie M. Shaw, Magdalena Korecka, Shreeram Aradhye et al. · The Journal of Clinical Pharmacology · 2000 · 134 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix

R. Scott Struthers, Andrew Nicholls, John S. Grundy et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 123 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H<sub>3</sub> Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease

Richard Grove, Conn Harrington, Andreas Mahler et al. · Current Alzheimer Research · 2014 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +17